Radiopharm Theranostics Limited (AU:RAD) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Radiopharm Theranostics Limited has announced a new application for the quotation of over 37 million securities under the code RADOA, which are options expiring in August 2026. This application, detailed in Appendix 2A, aligns with the ASX Listing Rules and marks a significant new development for the company’s financial instruments.
For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.